Abbott wins FDA approval for dual-energy AFib ablation catheter
Abbott (NYSE: ABT) received U.S. Food and Drug Administration approval for its TactiFlex Duo Ablation Catheter, Sensor Enabled, a device ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)